How do you pay?

How to pay the least

Lowest posted price

$185 a month

Jatenzo from Tolmar, without insurance.

  1. Sign up for JATENZO Savings Card.Print the card (PDF) 

No generic is sold yet.

Compare every option

Question
Brand nameJatenzo
Authorized generictestosterone undecanoate
Regular generictestosterone undecanoate
What you’d pay
Cash price$185a month with the maker’s card
Not soldThere isn’t one
Not soldNone sold yet
Same as Jatenzo?
The original
–
–

Brand nameThe maker’s card

JATENZO Savings Card

Savings card from Tolmar

No insurance $185 a month
Insurance · as little as $0 a month

The card takes up to $393 a month off your co-pay.

Print the card (PDF) 

See the offer on jatenzo.com

In the maker’s words

“With the JATENZO® Copay Card, eligible patients with commercial insurance may pay as little as $0 for their monthly prescription.”

“Cash patients, and those who choose not to use insurance, can purchase a 1-month supply of JATENZO for $185.”

From the maker’s offer on jatenzo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Jatenzo itself, from the same company, sold without the brand name, and usually for less. For now Jatenzo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

JATENZO (testosterone undecanoate) is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

Limitations of use:

  • Safety and efficacy of JATENZO in men with “age-related hypogonadism” have not been established
  • Safety and efficacy of JATENZO in males less than 18 years old have not been established.

Source: the FDA label for Jatenzo (TOLMAR Inc.), October 13, 2026. Full label on DailyMed 

Good to know